BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 13, 2005
View Archived Issues
Genentech Tallies Another Quarter Of Strong Earnings
Like a broken record playing a song investors never tire of hearing, Genentech Inc. chalked up another satisfying quarter, with Avastin and Herceptin sales benefiting from a parade of positive news this spring. (BioWorld Today)
Read More
Pharmacopeia, Allergan Enter Agreement For Wet AMD Drugs
Read More
From In Vivo Research Come Insights Into P53 Regulation
Read More
Nabi's StaphVAX Phase II Trial Confers Lofty Immunity Levels
Read More
Other News To Note
Read More
Appointments And Advancements
Read More